Oct 04, 2017
Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.
Oct 02, 2017
Alere Receives FDA Clearance for Alere(TM) i Influenza A & B 2 Rapid Molecular Test
Sep 29, 2017
Alere Announces the U.S. Department of Justice Closes Investigation
Sep 29, 2017
Abbott Acquisition of Alere Set to Close on October 3, 2017
Sep 29, 2017
Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017
Sep 28, 2017
Alere Announces Settlement with SEC
Sep 28, 2017
Alere Announces Agreement in Principle to Settle with the U.S. Department of Justice
Sep 18, 2017
Alere Announces Intent to Voluntarily Delist Series B Convertible Perpetual Preferred Stock from the NYSE Conditioned Upon the Completion of its Acquisition by Abbott
Sep 18, 2017
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Sep 01, 2017
Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Aug 30, 2017
Global Lateral Flow Assay Market 2016-2022: Alere, Inc. (U.S.) Dominated the Market in 2016
Aug 14, 2017
Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Aug 11, 2017
Alere Provides Notice to Holders of Series B Convertible Perpetual Preferred Stock
Aug 03, 2017
Alere Reports Second Quarter 2017 Financial Results
Jul 31, 2017
Immunalysis Receives FDA Clearance for SEFRIA(TM) Fentanyl Urine Drug Screening Test
Jul 19, 2017
Alere Launches Alere iCup® Rx Drug Screen for Detecting Commonly Misused and Abused Prescription Drugs
Jun 23, 2017
Alere Inc. Declares Cash Dividend on its Series B Convertible Perpetual Preferred Stock
Jun 14, 2017
Alere Reports First Quarter 2017 Financial Results
Jun 05, 2017
Alere Inc. Announces Termination of Consent Solicitations for Alere Inc.'s Notes and Offers Consent Termination Fee
Jun 05, 2017
Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2016 Financial Results